Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer

被引：0
|
作者：
Yupeng Jiang [1 ]
Yuyao Liu [2 ]
Hong Huang [3 ]
Tiantian Zhao [1 ]
Zengyi Zhao [1 ]
Yawen Gao [1 ]
机构：
[1] The Second Xiangya Hospital,Department of Oncology
[2] Central South University,Department of Oncology
[3] The Affiliated Changsha Central Hospital,undefined
[4] Hengyang Medical School,undefined
[5] University of South China,undefined
[6] Guilin Medical University,undefined
来源：
Cancer Immunology, Immunotherapy | / 74卷 / 3期
关键词：
RAS mutation; High microsatellite instability; Deficient mismatch repair; Colorectal cancer; Tumor microenvironment;
D O I：
10.1007/s00262-024-03926-9
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers
    Wang, Zhenghang
    Cheng, Siyuan
    Yao, Yanhong
    Liu, Shengde
    Liu, Zimin
    Liu, Ning
    Jin, Yongdong
    Zhang, Yinjie
    Yin, Fei
    Han, Guangjie
    Zhang, Jingdong
    Wang, Qiwei
    Yan, Dong
    Wang, Li
    Lu, Hongxia
    Deng, Ting
    Ji, Zhi
    Gao, Hui
    Fang, Weijia
    Zhang, Hangyu
    Chen, Zhiyu
    Zou, Jianling
    Tang, Yong
    Xu, Chunlei
    Li, Jiayi
    Qu, Huajun
    Bao, Liying
    Cao, Baoshan
    Wang, Xicheng
    Xu, Ting
    Sun, Yu
    Shen, Lin
    Peng, Zhi
    Li, Jian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [42] Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
    Oliveira, Andre F.
    Bretes, Luis
    Furtado, Irene
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [43] Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature
    San-Roman-Gil, Maria
    Martinez-Delfrade, Inigo
    Albarran-Fernandez, Victor
    Guerrero-Serrano, Patricia
    Pozas-Perez, Javier
    Chamorro-Perez, Jesus
    Rosero-Rodriguez, Diana
    Sotoca-Rubio, Pilar
    Barrill-Corpa, Ana Maria
    Alia-Navarro, Victor
    Gonzalez-Merino, Carlos
    Garcia-de-Quevedo-Suero, Coral
    Lopez, Victoria
    Ruz-Caracuel, Ignacio
    Perna-Monroy, Cristian
    Ferreiro-Monteagudo, Reyes
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [44] SYSTEMATIC AND STRUCTURED REVIEWS OF THE DISEASE BURDEN IN PATIENTS WITH MICROSATELLITE INSTABILITY HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) COLORECTAL CANCER (CRC)
    Amonkar, M.
    Chase, M.
    Takyar, J.
    Sharma, S.
    VALUE IN HEALTH, 2021, 24 : S24 - S24
  • [45] Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States
    Aguiar-Ibanez, Raquel
    Hardern, Chloe
    van Hees, Frank
    Lee, Dawn
    Patel, Anubhav
    Chhabra, Nitika
    Baluni, Gargi
    Amonkar, Mayur
    Lai, Yizhen
    Xu, Ruifeng
    Massaad, Rachid
    Fogelman, David
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 469 - 480
  • [46] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Janindra Warusavitarne
    Margaret Schnitzler
    International Journal of Colorectal Disease, 2007, 22 : 739 - 748
  • [47] Is MSI-H of value in predicting the development of metachronous colorectal cancer?
    Lawes, DA
    Pearson, T
    SenGupta, S
    Boulos, PB
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 473 - 476
  • [48] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
    Andre, Thierry
    Pietrantonio, Filippo
    Avallone, Antonio
    Gumus, Mahmut
    Wyrwicz, Lucjan
    Kim, Jong Gwang
    Yalcin, Suayib
    Kwiatkowski, Mariusz
    Lonardi, Sara
    Zolnierek, Jakub
    Odeleye-Ajakaye, Amos
    Leconte, Pierre
    Fogelman, David
    Kim, Tae Won
    FUTURE ONCOLOGY, 2023, 19 (37) : 2445 - 2452
  • [49] Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
    Okuma, Hitomi S.
    Watanabe, Keisuke
    Tsuchihashi, Kenji
    Machida, Ryunosuke
    Sadachi, Ryo
    Hirakawa, Akihiro
    Ariyama, Hiroshi
    Kanai, Masashi
    Kamikura, Masahisa
    Anjo, Kenta
    Hiramitsu, Akari
    Sekine, Shigeki
    Okita, Natsuko
    Mano, Hiroyuki
    Nishikawa, Hiroyoshi
    Nakamura, Kenichi
    Yonemori, Kan
    CLINICAL CANCER RESEARCH, 2023, 29 (24) : 5079 - 5086
  • [50] The mutational landscape of MSI-H and MSS colorectal cancer.
    Li, Enxiao
    Hu, Ying
    Han, Wenbo
    Liu, Tianshu
    Lv, Fang
    Zhao, Lili
    Liu, Yang
    Chen, Yanhui
    Zhang, Henghui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345